《亞洲股市》亞太股市普遍反覆向好 港股升幅擴至近250點
美國3月ISM製造業PMI及2月建築開支均遠遜預期,3月非農新增職位放緩至43.1萬個也低預期,但前值上修7.2萬個至飆升75萬個,且3月失業率降至3.6%逾兩年低勝預期,且時薪年增加快至5.6%略高預期,數據公佈後,市場預計聯儲局下月仍有逾七成機會加息半釐,債息隨即抽升,被市場視爲經濟衰退訊號的2年期與10年期債息曲線一週來第三次出現倒掛,美股上週五表現反覆,三分二藍籌向好,支持道指反覆(上下波幅逾300點)回升139點或0.4%;英特爾(INTC.US)跌2.9%,已兩連跌費城半導體指數再跌1.8%三天累挫逾7%,拖累納指及標指僅回升0.3%。此外,歐洲主要股市在銀行和商品股帶動全面反彈0.2%-0.7%。
美股期貨全面回吐0.1%-0.2%。亞太股市早段普遍反覆向好。美元兌日圓繼上週五於紐約回升0.7%後,今早於亞洲反覆微跌0.1%,現報122.4。日經三連跌後,今早回升至27,754遇壓,曾倒跌低見27,578,現報27,673,回升7點。
然而,澳洲200終止兩連軟,最高見7,536,現報7,520,回升0.4%。新西蘭50指數繼上週五回軟後,今早反覆向好,現報12,103,回升0.1%。南韓(KOSPI)繼上週五回軟結束三連升後,今早反覆回升,最低見2,722,現報2,748,回升0.3%。新加坡海峽指數報3,421,續升2點。
港股繼上週五收復曾續跌438點所有失地倒升42點後,今早在比亞迪(01211.HK)、碧桂園服務(06098.HK)、騰訊(00700.HK)、京東(09618.HK)、美團(03690.HK)、碧桂園(02007.HK)和網易(09999.HK)高開1.5%-3.5%,以及新冠疫苗獲內地批準展開臨牀研究的石藥(01093.HK)高開6.1%帶動,恆指高開187點或近0.9%,升幅擴至244點或1.1%,報22,283。
然而,吉隆坡綜合指數繼上週五續彈近1%後,今早扭兩連升,報1,597,逆吐0.3%。滬深及臺股假期休市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.